Immunis, a private biotechnology company developing a novel treatment for age and disease-related immune decline, has appointed Neil Sahota as its Chief Artificial Intelligence (AI) Officer. AI is a tool that is transforming the way businesses and scientists integrate information, conduct data analysis, and make informed decisions on how to optimize growth. For over 20 years, Neil has inspired AI modernization through technology-based business strategies and has been successful in helping businesses become leaders in the digital future. Immunis is confident that Neil will guide the company to unlock the considerable potential of AI in biotech.
AiThority Interview Insights: AiThority Interview with at Brian Sathianathan, Co-Founder and CTO at Iterate.ai
Immunis is confident that Neil will guide the company to unlock the considerable potential of AI in biotech.
As a United Nations artificial intelligence (AI) Advisor and a former IBM Master Inventor, Neil fosters innovation and develops next generation products powered by AI. At IBM, Neil reviewed and guided the development of patents and drove economic development projects to shape the next generation of IBM AI products and services. Partnering with entrepreneurs, Neil helps new businesses establish their target markets and assists with strategic development.
Read More about AiThority Interview: AiThority Interview with Thomas Kriebernegg, Managing Director & Co-Founder at App Radar
Neil is an advocate for social good. He serves on the Orange County Marathon Board of Directors to support the fight against childhood obesity, volunteers with the Zero Abuse Project whose mission is to ensure every child is free from abuse, and promotes youth sustainability initiatives with Planet Home. In addition to being a philanthropist and renowned speaker, Neil authored the best-seller, Own the AI Revolution, which advises on strategies for business growth using AI.
Immunis is delighted to welcome an incredible trailblazer in AI strategy to the team. As AI is already altering the way businesses engage in decision making, we welcome the adaptation of seemingly limitless technology to enhance Immunis’ contribution to the world.
Latest AiThority Interview Insights : AiThority Interview with Joshua Wilson, Commercial Director, JAPAC at Crimtan
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.